Evidence map›Paper›PMID 38306491›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2024

New Manual Quantitative Polymerase Chain Reaction Assay Validated on Tongue Swabs Collected and Processed in Uganda Shows Sensitivity That Rivals Sputum-based Molecular Tuberculosis Diagnostics.

Amy Steadman, Alfred Andama, Alexey Ball, Job Mukwatamundu, Khushboo Khimani, Tessa Mochizuki, Lucy Asege, Alice Bukirwa, John Baptist Kato, David Katumba and 16 more

Registry-linked trialAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07293455 (Evaluation and Demonstration of New Tuberculosis Diagnostics for Indonesia; Work Package 3), which is not on this map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07293455 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Evaluation and Demonstration of New Tuberculosis Diagnostics for Indonesia; Work Package 3: Cluster Randomised Controlled Trial of A Diagnostic Package to Increase the Number of Tuberculosis Cases Notified

TypeinterventionalSponsorUniversitas PadjadjaranRan2026 to 2027Enrolled40,000ConditionsTuberculosisArmsnPOC Testing Intervention Package
3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Diagnostic Accuracy of Molecular Testing on Saliva and Oral Swabs for Pulmonary Tuberculosis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  5. Article
  6. Development of a Rapid Automated Point-of-Care Test formedRxiv : the preprint server for health sciences · 2026
    Article
  7. Preferences for tongue swab versus sputum collection for TB testing: a multi-country survey.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2026
    Article
  8. Review
  9. Tongue swabmedRxiv : the preprint server for health sciences · 2026
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors.

Amy SteadmanGlobal Health Labs, Inc, Bellevue, Washington, USA.ORCID 0000-0002-5605-1240
Alfred AndamaDepartment of Internal Medicine, Makerere University College of Health Sciences, Kampala, Uganda.ORCID 0000-0003-0526-0007
Alexey BallGlobal Health Labs, Inc, Bellevue, Washington, USA.
Job MukwatamunduWalimu, Kampala, Uganda.ORCID 0009-0008-5714-3797
Khushboo KhimaniGlobal Health Labs, Inc, Bellevue, Washington, USA.
Tessa MochizukiCenter for Tuberculosis, University of California-San Francisco, San Francisco, California, USA.
Lucy AsegeWalimu, Kampala, Uganda.ORCID 0000-0002-6591-3180
Alice BukirwaWalimu, Kampala, Uganda.
John Baptist KatoWalimu, Kampala, Uganda.
David KatumbaWalimu, Kampala, Uganda.
Esther KisakyeWalimu, Kampala, Uganda.
Wilson MangeniWalimu, Kampala, Uganda.
Sandra MwebeWalimu, Kampala, Uganda.ORCID 0000-0003-0184-3598
Martha NakayeWalimu, Kampala, Uganda.
Irene NassunaWalimu, Kampala, Uganda.
Justine NyawereWalimu, Kampala, Uganda.
Annet NakaweesaWalimu, Kampala, Uganda.
Catherine CookCenter for Tuberculosis, University of California-San Francisco, San Francisco, California, USA.
Patrick PhillipsCenter for Tuberculosis, University of California-San Francisco, San Francisco, California, USA.ORCID 0000-0002-6336-7024
Talemwa NalugwaWalimu, Kampala, Uganda.ORCID 0000-0001-8798-1005
Christine M BachmanGlobal Health Labs, Inc, Bellevue, Washington, USA.ORCID 0000-0002-8143-2782
Fred Collins SemitalaDepartment of Internal Medicine, Makerere University College of Health Sciences, Kampala, Uganda.ORCID 0000-0002-0624-7640
Bernhard H WeiglGlobal Health Labs, Inc, Bellevue, Washington, USA.ORCID 0000-0003-4178-2638
John ConnellyGlobal Health Labs, Inc, Bellevue, Washington, USA.ORCID 0000-0003-3732-3789
William WorodriaDepartment of Internal Medicine, Makerere University College of Health Sciences, Kampala, Uganda.ORCID 0000-0002-8531-5567
Adithya CattamanchiDivision of Pulmonary Diseases and Critical Care Medicine, University of California-Irvine, Irvine, California, USA.ORCID 0000-0002-6553-2601

Funding

Rapid Research for Diagnostics Development in TB Network (R2D2 TB Network)U01AI152087 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CATTAMANCHI, ADITHYA, DENKINGER, CLAUDIA MARIA · 2020 to 2024
$19.3M
Research Mentoring and Building Capacity of underrepresented Minority Research Scientists in India.D43TW010540 · FIC · YALE UNIVERSITY · PI MICHELE BARRY, Eva Harris · 2017 to 2026
$15.5M
FIC NIH HHS D43 TW010540NIAID NIH HHS U01 AI152087NIH HHS U01AI152087
6 · The paper itself

Abstract

backgroundSputum-based testing is a barrier to increasing access to molecular diagnostics for tuberculosis (TB). Many people with TB are unable to produce sputum, and sputum processing increases assay complexity and cost. Tongue swabs are emerging as an alternative to sputum, but performance limits are uncertain.

methodsFrom June 2022 to July 2023, we enrolled 397 consecutive adults with cough >2 weeks at 2 health centers in Kampala, Uganda. We collected demographic and clinical information, sputum for TB testing (Xpert MTB/RIF Ultra and 2 liquid cultures), and tongue swabs for same-day quantitative polymerase chain reaction (qPCR) testing. We evaluated tongue swab qPCR diagnostic accuracy versus sputum TB test results, quantified TB targets per swab, assessed the impact of serial swabbing, and compared 2 swab types (Copan FLOQSWAB and Steripack spun polyester).

resultsAmong 397 participants, 43.1% were female, median age was 33 years, 23.5% were diagnosed with human immunodeficiency virus, and 32.0% had confirmed TB. Sputum Xpert Ultra and tongue swab qPCR results were concordant for 98.2% (95% confidence interval [CI]: 96.2-99.1) of participants. Tongue swab qPCR sensitivity was 92.6% (95% CI: 86.5 to 96.0) and specificity was 99.1% (95% CI: 96.9 to 99.8) versus microbiological reference standard. A single tongue swab recovered a 7-log range of TB copies, with a decreasing recovery trend among 4 serial swabs. Swab types performed equivalently.

conclusionsTongue swabs are a promising alternative to sputum for molecular diagnosis of TB, with sensitivity approaching sputum-based molecular tests. Our results provide valuable insights for developing successful tongue swab-based TB diagnostics.

Indexed as

Mycobacterium tuberculosisReal-Time Polymerase Chain ReactionSensitivity and SpecificitySpecimen HandlingSputumTongueAdultFemaleHumansMaleMiddle AgedMolecular Diagnostic TechniquesTuberculosisTuberculosis, PulmonaryUgandaYoung Adultdiagnosisnonsputumoral swabtongue swabtuberculosis

Identifiers

PMID38306491
PMCPMC11093664

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.